project id: TCGA-BRCA; case submitter id: TCGA-LD-A74U; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.44; rna integrity number: 8.6; age at index: 79; days to birth: -28981; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 28981; ajcc pathologic m: M0; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 402.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8524/3; primary diagnosis: Infiltrating lobular mixed with other types of carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 59; days to sample procurement: 0; portion submitter id: TCGA-LD-A74U-01A-01; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;